Search All News
Data scientists from Columbia University and around the world are starting to use the world’s electronic health records and databases to identify the best therapies for treating COVID-19 patients.
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus.
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
Non-medical cannabis use—including frequent or problematic use—is more common in adults with pain than in those without pain, a new study from Columbia University Irving Medical Center has found.
- November 19, 2018
A new program at Columbia is looking for earlier signs of ALS so that future treatments can be delivered before extensive neurological damage occurs.
- November 15, 2018
The most common tests for glaucoma can underestimate the severity of the condition because they do not detect the presence of central vision loss, ophthalmologists at Columbia have found.
- November 14, 2018
With a genome that’s regularly broken into 225,000 pieces and reassembled, a pond protist may be the perfect creature to teach us how genomic stability—often lost in cancer—is maintained.
- October 5, 2018
Community health workers may be able to help youths with sickle cell disease live healthier lives, according to a new study from Columbia's School of Nursing and Department of Pediatrics.
- September 21, 2018
Columbia University awards the 2018 Louisa Gross Horwitz Prize to Pierre Chambon, Ronald M. Evans, and Bert W. O’Malley for their research—spanning over 50 years—decoding how steroid hormones and nuclear receptors regulate cell function.
- September 17, 2018
A new study finds that regulatory gene variants can affect the severity of a genetic disease among people with the same protein-coding mutation.